1. Home
  2. LXEO vs FNLC Comparison

LXEO vs FNLC Comparison

Compare LXEO & FNLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXEO
  • FNLC
  • Stock Information
  • Founded
  • LXEO 2017
  • FNLC 1864
  • Country
  • LXEO United States
  • FNLC United States
  • Employees
  • LXEO N/A
  • FNLC N/A
  • Industry
  • LXEO
  • FNLC Major Banks
  • Sector
  • LXEO
  • FNLC Finance
  • Exchange
  • LXEO Nasdaq
  • FNLC Nasdaq
  • Market Cap
  • LXEO 252.4M
  • FNLC 295.4M
  • IPO Year
  • LXEO 2023
  • FNLC 1999
  • Fundamental
  • Price
  • LXEO $4.88
  • FNLC $26.32
  • Analyst Decision
  • LXEO Strong Buy
  • FNLC
  • Analyst Count
  • LXEO 5
  • FNLC 0
  • Target Price
  • LXEO $23.80
  • FNLC N/A
  • AVG Volume (30 Days)
  • LXEO 210.0K
  • FNLC 23.0K
  • Earning Date
  • LXEO 01-28-2025
  • FNLC 01-27-2025
  • Dividend Yield
  • LXEO N/A
  • FNLC 5.40%
  • EPS Growth
  • LXEO N/A
  • FNLC N/A
  • EPS
  • LXEO N/A
  • FNLC 2.38
  • Revenue
  • LXEO N/A
  • FNLC $78,192,000.00
  • Revenue This Year
  • LXEO N/A
  • FNLC N/A
  • Revenue Next Year
  • LXEO N/A
  • FNLC N/A
  • P/E Ratio
  • LXEO N/A
  • FNLC $10.98
  • Revenue Growth
  • LXEO N/A
  • FNLC N/A
  • 52 Week Low
  • LXEO $4.78
  • FNLC $21.77
  • 52 Week High
  • LXEO $19.50
  • FNLC $31.05
  • Technical
  • Relative Strength Index (RSI)
  • LXEO 29.67
  • FNLC 45.52
  • Support Level
  • LXEO $4.78
  • FNLC $25.91
  • Resistance Level
  • LXEO $7.66
  • FNLC $26.71
  • Average True Range (ATR)
  • LXEO 0.56
  • FNLC 0.57
  • MACD
  • LXEO -0.17
  • FNLC 0.03
  • Stochastic Oscillator
  • LXEO 3.47
  • FNLC 53.79

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.

About FNLC First Bancorp Inc (ME)

First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.

Share on Social Networks: